Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT01401985
PHASE2

A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

Sponsor: Glycyx Therapeutics

View on ClinicalTrials.gov

Summary

A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation

Official title: A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

95

Start Date

2011-10

Completion Date

2012-08

Last Updated

2026-05-22

Healthy Volunteers

No

Interventions

DRUG

TD-1211

Capsules

DRUG

Placebo

Capsules

Locations (1)

Theravance Biopharma Investigational Site

Pasadena, California, United States